Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Quantification of gait kinematics and walking ability of people with multiple sclerosis who are new users of functional electrical stimulation.
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.
Ampyra for Optic Neuritis in MS
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
[Neuromyelitis optica: a case report].
CD14 is a key organizer of microglial responses to CNS infection and injury.
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
The medicalisation of revolt: a sociological analysis of medical cannabis users.
Reverse causality behind the association between reproductive history and MS.
Multiple sclerosis, blood flow, and CSF circulation.
Alemtuzumab for multiple sclerosis: who and when to treat?
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
The pathogenic role of the inflammasome in neurodegenerative diseases.
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
Sleep and oligodendrocyte functions.
Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Anorexia heralding the onset of neuromyelitis optica.
Rare Inflammatory Diseases of the White Matter and Mimics of Multiple Sclerosis and Related Disorders.
Research Advances in Biomarkers for Demyelinating Optic Neuritis.
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Pages
« first
‹ previous
…
225
226
227
228
229
230
231
232
233
…
next ›
last »